The potential impact of discrepancies between automated susceptibility platforms and other testing metho`dologies for cefazolin in the treatment of Enterobacterales bloodstream infections-Reference-Cited by-同舟云学术

The potential impact of discrepancies between automated susceptibility platforms and other testing metho`dologies for cefazolin in the treatment of Enterobacterales bloodstream infections

Published:2021-10 Issue:2 Volume:101 Page:115483
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

Noval Mandee,Heil Emily L.,Williams Paula,Johnson J. Kristie,Claeys Kimberly C.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference16 articles.

1. Clinical and Laboratory Standards Institute (CLSI).Verification of commercial microbial identification and antimicrobial susceptibility testing systems, 1st Edition. Available at:https://clsi.org/standards/products/microbiology/documents/m52/. Accessed May 25, 2020.

2. Effect of the 2014 clinical and laboratory standards Institute urine-specific breakpoints on cefazolin susceptibility rates at a community teaching hospital;Chastain;Ann Clin Microbiol Antimicrob,2017

3. Reduced mortality with early infectious disease consultation in patients with AmpC gram-negative bacteremia;Cherabuddi;Open Forum Infect Dis,2017

4. European Committee on Antimicrobial Susceptibility Testing (EUCAST). Development and validation of EUCAST Disk Diffusion breakpoints. Updated 2021. Available at:https://www.eucast.org/ast_of_bacteria/calibration_and_validation/. Accessed May 25, 2020.

5. Understanding and addressing CLSI breakpoint revisions: a primer for clinical laboratories;Humphries;J Clin Microbiol,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gram-Negative Infection;The Infectious Diseases Consult Handbook;2023